I'm Gordon Sanghera, Chief Executive of Oxford Nanopore ... 74% of our revenues are from our consumable sales of flow cells and kits. Our gross margin for the period was 58.8%, up 120 basis ...
Oxford Nanopore Technologies (ONT) has reported a steady performance in its 2024 Half Year Interim Results, with CEO Gordon Sanghera confirming the company's alignment with ...
Oxford Nanopore Technologies announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products. Never miss a story ...
Oxford Nanopore Technologies Plc, the DNA-sequencing firm whose shares have plunged since going public, is setting its sights on FTSE 250 index inclusion that would widen the pool of potential ...